Hemispherx Biopharma (NYSE American: HEB) stock observed trading -70.36% off 52-week high price. On the other end, the stock has been noted 21.27% away from low price over the last 52-weeks. The stock disclosed a move of -24.76% away from 50 day moving average and -46.61% away from 200 day moving average. Moving closer, we can see that shares have been trading -5.88% off 20-day moving average. It has market cap of $9.39M.

Hemispherx Biopharma (NYSE American: HEB) declared that Adam Pascale is retiring from the position of Chief Financial Officer after nearly a quarter century with the company.

Pascale joined Hemispherx in 1995 as an accounting manager, rising to the position of Chief Accounting Officer before being named CFO in 2016. Pascale has been an integral part of Hemispherx’s leadership team since being named CFO, helping to execute CEO Thomas K. Equels’ long-term business plan to test the company’s lead product Ampligen in the treatment of cancer. Most recently, Pascale helped guide the company’s successful reverse-stock split, which took effect June 10, 2019.

Although stepping down as CFO, Pascale will still be working with Hemispherx as a consultant to assist with the company’s quarterly and year-end financial reports. In fact, he timed his last day of September 15 to ensure that he could help the company file its 10-Q for the quarter ending June 30, 2019.

We deeply appreciate Adam’s service and his willingness to delay retirement while the company established a firm business foundation and while grooming a replacement, said CEO Thomas K. Equels. While he leaves on a well-deserved long vacation in September, we are grateful that upon his return he will still serve in a consulting capacity. The USA based company Hemispherx Biopharma moved with change of 0.00% to $4.39 with the total traded volume of 102539 shares in recent session versus to an average volume of 180.27K. The stock was observed in the 5 days activity at 5.53%. The one month performance of stock was -14.72%. HEB’s shares are at -37.64% for the quarter and driving a -67.98% return over the course of the past year and is now at -44.88% since this point in 2018.  Right now the stock beta is 0.78. The average volatility for the week and month was at 10.33% and 16.59% respectively. There are 2.14M shares outstanding and 2.01M shares are floated in market.

Leave a Reply

Your email address will not be published. Required fields are marked *